HOUSE BILL 553
J1 5lr3326
CF SB 94
By: Delegates Taveras, Boafo, Harrison, Holmes, Lehman, Terrasa, and Vogel
Introduced and read first time: January 22, 2025
Assigned to: Health and Government Operations
A BILL ENTITLED
1 AN ACT concerning
2 Maryland Medical Assistance Program – Self–Measured Blood Pressure
3 Monitoring
4 FOR the purpose of requiring, beginning on a certain date, the Maryland Medical
5 Assistance Program to provide coverage for self–measured blood pressure
6 monitoring for certain eligible Program recipients; requiring the Program to develop
7 and implement a certain education campaign; and generally relating to
8 self–measured blood pressure monitoring under the Maryland Medical Assistance
9 Program.
10 BY repealing and reenacting, without amendments,
11 Article – Health – General
12 Section 15–101(h), (j), and (l) and 15–103(a)(1)
13 Annotated Code of Maryland
14 (2023 Replacement Volume and 2024 Supplement)
15 BY repealing and reenacting, with amendments,
16 Article – Health – General
17 Section 15–103(a)(2)(xxiii) and (xxiv)
18 Annotated Code of Maryland
19 (2023 Replacement Volume and 2024 Supplement)
20 BY adding to
21 Article – Health – General
22 Section 15–103(a)(2)(xxv) and 15–141.6
23 Annotated Code of Maryland
24 (2023 Replacement Volume and 2024 Supplement)
25 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
26 That the Laws of Maryland read as follows:
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from exist in g l aw . *hb0553*

2 HOUSE BILL 553
1 Article – Health – General
2 15–101.
3 (h) “Program” means the Maryland Medical Assistance Program.
4 (j) “Self–measured blood pressure monitoring” means the regular measurement
5 of blood pressure by the patient outside the clinical setting, either at home or elsewhere,
6 requiring the use of a home blood pressure measurement device by the patient.
7 (l) “Validated home blood pressure monitor” means a blood pressure
8 measurement device that has been validated for accuracy and is listed in the U.S. Blood
9 Pressure Validated Device Listing.
10 15–103.
11 (a) (1) The Secretary shall administer the Maryland Medical Assistance
12 Program.
13 (2) The Program:
14 (xxiii) Beginning on July 1, 2025, shall provide, subject to the
15 limitations of the State budget, and as permitted by federal law, coverage for biomarker
16 testing in accordance with § 15–859 of the Insurance Article; [and]
17 (xxiv) Beginning on January 1, 2025, shall provide coverage for
18 prostheses in accordance with § 15–844 of the Insurance Article; AND
19 (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE,
20 SUBJECT TO THE LIMITATIONS OF THE STATE BUDGET, AND AS PERMITTED BY
21 FEDERAL LAW, COVERAGE FOR SELF–MEASURED BLOOD PRESSURE MONITORING
22 FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS
23 SUBTITLE.
24 15–141.6.
25 (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
26 INDICATED.
27 (2) “ELIGIBLE PROGRAM RECIPIENT” MEANS A PROGRAM
28 RECIPIENT WHO:
29 (I) IS PREGNANT;
30 (II) IS POSTPARTUM; OR

HOUSE BILL 553 3
1 (III) HAS BEEN DIAGNOSED WITH:
2 1. CHRONIC KIDNEY DISEASE;
3 2. DIABETES;
4 3. HEART DISEASE; OR
5 4. A CARDIOMETABOLIC DISEASE.
6 (3) “HEALTH CARE PROVIDER” MEANS:
7 (I) A PERSON WHO IS LICENSED, CERTIFIED, OR OTHERWISE
8 AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HEALTH
9 CARE IN THE ORDINARY COURSE OF BUSINESS OR PRACTICE OF A PROFESSION, OR
10 IN AN APPROVED EDUCATION OR TRAINING PROGRAM; OR
11 (II) A COMMUNITY HEALTH WORKER CERTIFIED UNDER TITLE
12 13, SUBTITLE 37 OF THIS ARTICLE.
13 (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF–MEASURED
14 BLOOD PRESSURE MONITORING FOR ALL ELIGIBLE PROGRAM RECIPIENTS,
15 INCLUDING:
16 (1) THE PROVISION OF VALIDATED HOME BLOOD PRESSURE
17 MONITORS; AND
18 (2) REIMBURSEMENT OF HEALTH CARE PROVIDER AND OTHER STAFF
19 TIME USED FOR PATIENT TRAINING, TRANSMISSION OF BLOOD PRESSURE DATA,
20 INTERPRETATION OF BLOOD PRESSURE READINGS AND REPORTING, REMOTE
21 PATIENT MONITORING, AND THE DELIVERY OF CO–INTERVENTIONS, INCLUDING
22 EDUCATIONAL MATERIALS OR CLASSES.
23 (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDUCATION
24 CAMPAIGN TO INFORM ELIGIBLE PROGRAM RECIPIENTS AND HEALTH CARE
25 PROVIDERS ABOUT THE BENEFITS AND USAGE OF BLOOD PRESSURE MONITORING
26 TECHNOLOGY AND THE AVAILABILITY OF ASSISTANCE WITH SETUP AND
27 TROUBLESHOOTING.
28 (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE
29 DEPARTMENT SHALL SUBMIT A REPORT TO THE SENATE FINANCE COMMITTEE AND
30 THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN

4 HOUSE BILL 553
1 ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT
2 INCLUDES:
3 (1) THE TOTAL NUMBER OF ELIGIBLE PROGRAM RECIPIENTS WHO
4 RECEIVED BLOOD PRESSURE MONITORS UNDER THIS SECTION DURING THE
5 IMMEDIATELY PRECEDING 12–MONTH PERIOD;
6 (2) THE OUTCOMES ASSOCIATED WITH THE USE OF THE HOME BLOOD
7 PRESSURE MONITORS UNDER THIS SECTION; AND
8 (3) ANY COST SAVINGS ACHIEVED BY THE PROGRAM DURING THE
9 IMMEDIATELY PRECEDING FISCAL YEAR ASSOCIATED WITH THE USE OF THE HOME
10 BLOOD PRESSURE MONITORS DISTRIBUTED IN ACCORDANCE WITH THIS SECTION.
11 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July
12 1, 2025.

[DELETED: :CA      5   C A M M F t p o r b o a c d t M M A P t p c f s b p m a i a c e c a g r t s P B  A S  A  ( B  A S  A  ( B  A S  A  (  S T]
[DELETED:  H  A 1  ( “  ( “ o r  ( “ h b p m m a b p m P 1  ( ( T S s a t M M A P   ( T    ( o J 1 2 s p s t t l t a]    ( o J 1 2 s p c f p  ()BJ1,2,VE O A   S PE T T L O T T BT A A P BW FM R   §1 () ( N ( “EP” R RT M A R  () I;S  () I;ISM ]
[DELETED: H 3  () H:IA   1 C;   2 D;   3 H;E    4 A. ( “H”:R   () A, D D  E C RON M   () AI  I,S37.U  () TPH R S P C F SFM P M F A E R RS (  P O V H B PS  (  U F P TG T O B P DA O B P R A RG R MG A T D O COIS I– () TH R S D A I A E T I E R R A H C A T A O A W S A() OD1,2N O B E  E YR B I  TSF E I O O E A O P OE IHGOC]
[DELETED:  H  W   O T T O RE T27SGA ( T T N O E R R W B P M U T S D T M–; ( N  ( A C S A B T R D T  S 1]